cagrilintide tirzepatide combination trial Novo Nordisk: Can CagriSema Show 25% Weight Loss In REDEFINE-1 Trial? CagriSema: Strong Obesity Data, but

Peptide WH was relatively stable in simulated gastrointestinal digestion and was able to maintain the IC 50 value for -glucosidase inhibition (17.03 0.05 mol/L), whereas WS significantly increased the IC 50 value after simulated digestion (24.71 0.02 mol/L to 44.63 0.03 mol/L) (68)

Why humans are hardwired to crave sweetness [A: 13:30, V: 13:15]

Research has explored its effects on adipose tissue, body composition, and metabolic rate regulation

Sutherland A, Meldon C, Harrison T, Miller M

Research has identified that family support, the presence of co-occurring mental health disorders, and socioeconomic factors play significant roles in recovery outcomes